scispace - formally typeset
Open AccessJournal Article

Prevalence and clinical characteristics of dactylitis in spondylarthritis: a descriptive analysis of 275 patients.

TLDR
Dactylitis is a frequent manifestation in SpA particularly in peripheral disease and it may be the first manifestation of the disease with localisation being more frequent in the toes.
Abstract
OBJECTIVES Dactylitis is a common but little studied feature of spondylarthritis (SpA). Our objective was to assess the prevalence of dactylitis among a cohort of patients with spondylarthritis in a tertiary care centre and to describe the clinical characteristics of dactylitis. METHODS This was a prospective single centre observational study carried out in 2010. The patients included had been diagnosed as having definite SpA based on Amo's criteria. Each patient was interviewed by a physician. The data collected included prevalence of dactylitis and its clinical characteristics, effectiveness of the different treatments, and association with severe manifestations of SpA, and analysed by descriptive analysis. RESULTS 275 consecutive SpA patients were assessed: mean age 43.2±13.5 years, mean disease duration 14.0±11.8 years, 169 (61.4%) were men. In all, 59 patients (21.5%) suffered from SpA-associated dactylitis. The localisation of dactylitis was toes in 46 patients (78.0%) and/or fingers in 25 patients (42.4%). The most frequent localisations were the second toe and the second finger. Dactylitis was the first symptom of SpA in 14 patients (5.1%), and 28.8% (n=17) of dactylitis appeared within the first 5 years of disease. Dactylitis was present in 35.1% (n=13) of patients with undifferenciated SpA and in 30.6% (n=15) of patients with psoriatic arthritis. It was significantly associated with history of peripheral arthritis or heel pain. In our population, there was no correlation between dactylitis and HLA B27 status or sex and it was not a marker of severity of disease. CONCLUSIONS Dactylitis is a frequent manifestation in SpA (21.5%) particularly in peripheral disease and it may be the first manifestation of the disease with localisation being more frequent in the toes.

read more

Citations
More filters
Journal ArticleDOI

The Epidemiology of Psoriatic Arthritis.

TL;DR: In this review, current knowledge is discussed regarding the epidemiology of PsA, including disease manifestations, classification criteria for adult and juvenilePsA, methods for recognizing early PsA; use of screening tools and knowledge of risk factors for PsA%; and medical comorbidities associated with PsA.
Journal ArticleDOI

Enthesitis in psoriatic arthritis.

TL;DR: Enthesitis and dactylitis are important manifestations of PsA, and their evaluation is increasingly used in drug trials and clinical practice.
Journal ArticleDOI

Classification and Diagnosis of Axial Spondyloarthritis — What Is the Clinically Relevant Difference?

TL;DR: A analysis of differences between classification and diagnostic criteria for axial spondyloarthritis by discussing each feature of the classification criteria based on real cases is hoped to increase the understanding of diagnosing axSpA in relation to the ASAS classification criteria.
Journal ArticleDOI

Epidemiological analysis of psoriatic arthritis patients in Japan.

TL;DR: The ratio of psoriatic arthritis in Japan is increasing, and nearly 10% of new psoriasis patients had psoriatics arthritis, including several unexpected findings such as male predominance, longer duration between the onset of cutaneous Psoriasis and arthritis, and dominance of polyarthritis.
References
More filters
Journal ArticleDOI

Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

TL;DR: The study showed the clinical history screening test for AS to be moderately sensitive, but it might be better in clinical practice, and substitution of the Rome pain criterion for the New York pain criterion is proposed.
Journal ArticleDOI

Classification criteria for psoriatic arthritis: Development of new criteria from a large international study

TL;DR: The CASPAR criteria are simple and highly specific but less sensitive than the Vasey and Espinoza criteria and are confirmed as the validity of clinical diagnosis as the gold standard definition of "case"-ness.
Journal ArticleDOI

Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double‐blind, randomized, placebo‐controlled trial

TL;DR: Adalimumab significantly improved joint and skin manifestations, inhibited structural changes on radiographs, lessened disability due to joint damage, and improved quality of life in patients with moderately to severely active PsA.
Related Papers (5)